Merck (MRK) pulls out of the COVID-19 vaccine race; will focus on investigational therapeutic candidates
Merck & Co. Inc. (NYSE: MRK) has decided to discontinue the development of its COVID-19 vaccine candidates after its clinical trials yielded disappointing results. Shares…